What are the key financial targets outlined by Chemours CFO Shane Hostetter under the 'Pathway to Thrive' strategy?

Chemours CFO Shane Hostetter outlined a 'Pathway to Thrive' strategy targeting $250 million in cost reductions by 2027 and forecasting an adjusted EBITDA of $800–$900 million for the year.

How does Chemours CFO Shane Hostetter characterize the company's progress on PFAS-related environmental liabilities and internal controls?

Shane Hostetter stated that Chemours has resolved its PFAS-related environmental liabilities and has taken steps to strengthen internal controls following a leadership shakeup.

Chemours CFO talks PFAS, tariffs and internal controls

May 13, 2026

Chemours CFO Shane Hostetter targets $250 million in cost reductions by 2027 with an adjusted EBITDA forecast of $800-$900 million. He addressed PFAS liabilities, tariff benefits for Titanium Technologies, and strengthened internal controls.

CFO Dive

2026-04-17

Chemours' Fayetteville Works Earns Gold-Level WHC Conservation Certification for Environmental Excellence

2026-04-18

Chemours Company Receives Average 'Hold' Recommendation from Brokerages

2026-04-21

Chemours' West Virginia Forest Partnership Delivers Measurable Climate and Community Impact After Five Years

2026-04-21

Chemours to Release Q1 2026 Results May 5, Host Webcast

2026-04-22

Activists Demand No-Mining Pledge Near Okefenokee Swamp from Chemours